CanadaBis Capital (TSXV:CANB) Moat Score: 2/10 (As of Jul. 07, 2026)


What is CanadaBis Capital Moat Score?

CanadaBis Capital TSXV:CANB Moat Score is 2 as of Jul. 07, 2026. The stock has 6 warning signs investors should review. Among 1,032 Drug Manufacturers companies, CanadaBis Capital ranks better than 81.59% on this metric.

CanadaBis Capital has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

CanadaBis Capital has No Moat: CanadaBis Capital Inc operates in a competitive cannabis market with no significant market leadership or durable cost advantages. It lacks strong brand strength, intellectual property, and regulatory barriers. The company's competitive position is very weak with no discernible moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes CanadaBis Capital might have No Moat - Very weak/transient advantages.

CanadaBis Capital  (TSXV:CANB) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

CanadaBis Capital Moat Score Related Terms

TSXV:CANB vs NPHC, BSPK, CPMD: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanadaBis Capital Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Moat Score distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's Moat Score falls into.


Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
CanadaBis Capital (TSXV:CANB) has a Moat Score of 2 as of Jul. 07, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, CanadaBis Capital ranks #190 out of 1032 companies in the Drug Manufacturers industry, placing it in the top 18.4%.
Is CanadaBis Capital's Moat Score too high?
CanadaBis Capital's current Moat Score is 2. Based on the distribution chart, CanadaBis Capital ranks #190 out of 1032 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does CanadaBis Capital's Moat Score compare to NPHC and BSPK?
According to the Drug Manufacturers industry distribution chart, CanadaBis Capital ranks #190 out of 1032 companies for Moat Score. This places CanadaBis Capital in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. CanadaBis Capital's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (TSXV:CANB) has a current Moat Score of 2. The stock's GF Value™ is C$0.07, compared to a current price of C$0.02 — trading 78.6% below its estimated fair value. The current Moat Score is 2. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For CanadaBis Capital (TSXV:CANB), the current Moat Score is 2 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CanadaBis Capital Business Description

Other Exchanges CNADF:USA
Address 255C Clearview Drive, Red Deer County, Red Deer, AB, CAN, T4E 3B6
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.